The Role of the 21-Gene Recurrence Score(®) Assay in Hormone Receptor-Positive, Node-Positive Breast Cancer: The Canadian Experience

The management of patients with hormone receptor-positive breast cancer has changed dramatically with use of the 21-gene Recurrence Score(®) (RS) Assay. While the utility of the assay was initially demonstrated among node-negative patients, recent studies have also demonstrated the assay’s prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yordanova, Mariya, Hassan, Saima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947241/
https://www.ncbi.nlm.nih.gov/pubmed/35323363
http://dx.doi.org/10.3390/curroncol29030163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947241/
https://www.ncbi.nlm.nih.gov/pubmed/35323363
http://dx.doi.org/10.3390/curroncol29030163

Ejemplares similares